Industries Market Research Reports
Subscribe to RSS Feed-
08 Jun 2018  |  North America  |  Market Research
US Cardiac Troponin Diagnostics Market, Forecast to 2021
High Prevalence of Heart Disease Propels Market Growth
Cardiac troponins help to diagnose nearly two-thirds of the patients in the diagnosis Acute Coronary Syndrome (ACS) who are missed out by Echocardiogram (ECG). ECG can detect only one-third of the patients with persistent ST-segment Elevation (STEMI), whereas cardiac troponins can distinguish patients without ST-segment elevation (NSTEACS; non-ST s...
$4,950.00 -
25 May 2018  |  Europe  |  Market Research
Western European Cardiac Troponin Diagnostics Market, Forecast to 2021
Emerging Biomarkers Disrupt and Spur Growth in the Heart Disease Segment
Cardiac troponins have now become the gold standard for early diagnosis of acute myocardial infarction, making them indispensable for clinical diagnosis of Acute Coronary Syndrome (ACS). Cardiac troponins play a key role in minimizing hospital stays and reducing admission rate which are the biggest contributors to overall healthcare expenditure. Fo...
$3,000.00 -
16 Apr 2018  |  Asia Pacific  |  Market Research
Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021
Increasing Incidence Rates of Myocardial Infarction and Aging Population in APAC Drive the Troponin Diagnostics Market
Cardiac troponins will continue to remain the gold standard for early diagnosis of acute myocardial infarction (AMI); however, the key challenge to address is the advent of a complementary biomarker to prevent repeat diagnosis. Multiplexing platforms should be harnessed for simultaneous testing of complementary biomarkers such as H-FABP, cardiac my...
$3,000.00 -
21 Dec 2017  |  North America  |  Market Research
Strategic Insight into the Global Women’s Oncology Diagnostics Market, 2017
Surge in Adoption of Next Generation Sequencing (NGS) Solutions for Predictive Diagnosis Transforms the IVD Testing Landscape
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00 -
21 Dec 2017  |  North America  |  Market Research
Strategic Insight into the Global Women’s Urology Diagnostics Market, 2017
Growth Spurred by Simple and Accurate Point of Care (POC) Testing at Home for Urological Conditions such as Nephrolithiasis and Urinary Tract Infections (UTIs)
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00 -
20 Dec 2017  |  North America  |  Market Research
Strategic Insight into the Global Women’s Cardiology Diagnostics Market, 2017
Integrated Devices and User-friendly Cardiac Monitoring Products Focused on Home Care Offer New Growth Opportunities
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00 -
18 Dec 2017  |  Global  |  Market Research
Strategic Insight into the Global Women’s Reproductive Health Diagnostics Market, 2017
Non-Invasive Prenatal Testing and Carrier Screening are the Key Segments Triggering Growth Across the Market
Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseas...
$1,500.00 -
30 Nov 2017  |  Europe  |  Market Research
Growth Opportunities in European Prenatal Genetic Testing Market, Forecast to 2021
Non-invasive Prenatal Testing (NIPT) Driven by the Adoption of Next Generation Sequencing (NGS) Techniques for Screening is Driving Market Growth
Prenatal genetic tests are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, 13 and carrier screens. They are gaining momentum in EU due to enhanced assay outcomes through non-invasive methodologies using next generation sequencing (NGS) techniques, increasing number of women choosing to undergo pregnancy at an advanc...
$3,000.00 -
25 Sep 2017  |  North America  |  Market Research
2017 Customer Attitudes and Adoption Plans of Digital Pathology Technologies
A Voice of Customer Study to Compare Trends Between Current and Potential Adopters of Digital Pathology Platforms
A digital pathology end-user research was conducted to identify trends and developments in the field of digital pathology. The survey sought to collect the key information on usage and adoption and compare the perceptions of current and potential adopters of this technology. For the survey, lab managers and pathologists of pathology facilities we...
$4,950.00 -
21 Jul 2017  |  North America  |  Market Research
Growth Opportunities in the US Prenatal Genetic Testing Market, Forecast to 2021
Rising Maternal Age, Improved Screening Algorithms Catering to Healthcare Payer Requirements, and Exploration of New Business Models Will Drive Market
Prenatal genetic tests, which are predominantly used to test disorders such as aneuploidies in chromosomes 21, 18, and 13, and carrier screens, are gaining momentum in the United States due to enhanced assay outcomes through non-invasive methodologies, increased popularity through social media channels, and the growing number of women choosing to u...
$4,950.00